Cobalt Single-Atom Nanozyme Co-Administration with Ascorbic Acid Enables Redox Imbalance for Tumor Catalytic Ablation
Source abstract
Abstract
The elevated antioxidant defense system in cancer cells can lead to resistance to treatments involving ROS. Breaking the redox balance of the cell system through a "open up the source and regulate the flow" strategy can inhibit the growth of cancer cells and thus design a cancer treatment strategy. Here, cobalt single atom-supported N-doped carbon nanozymes (Co SA-N/C) were synthesized via a simple sacrificial template method, which can mimic the properties of ascorbate oxidase and glutathione oxidase effectively. The synthesized Co SA-N/C can induce the generation of active oxygen by accelerating the oxidation of ascorbic acid (AA) and destroy the endogenous active oxygen scavenging system by consuming the main antioxidant, glutathione (GSH). In-depth in vitro and in vivo investigations indicate that compared with solo therapy, Co SA-N/C together with AA can significantly enhance the anti-tumor efficiency by simultaneously elevating oxidative stress and consuming the overexpressed glutathione (GSH) through the redox reaction catalyzed by Co SA-N/C. This work provides a promising route for developing nanozyme-guided and ascorbate-based antitumor agents.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Capital Normal University, Beijing 100048, China
Beijing Key Laboratory of Construction Tailorable Advanced Functional Materials and Green Applications, School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, China
Funding
Natural Science Foundation of Beijing Municipality · Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five-year Plan · National Natural Science Foundation of China
References (62)
Show source-provided references
1. 10.1126/sciadv.abb727210.1126/sciadv.abb7272 ↗
2. 10.1038/s41580-020-0230-310.1038/s41580-020-0230-3 ↗
3. 10.1002/adfm.20210410010.1002/adfm.202104100 ↗
4. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
5. 10.3390/cancers1108119110.3390/cancers11081191 ↗
6. 10.1002/adfm.20210358110.1002/adfm.202103581 ↗
7. 10.1002/anie.20190103510.1002/anie.201901035 ↗
8. 10.1021/acs.analchem.0c0222510.1021/acs.analchem.0c02225 ↗
9. 10.1021/ac070587110.1021/ac0705871 ↗
10. 10.1021/acssensors.0c0232610.1021/acssensors.0c02326 ↗
11. 10.1021/acsami.8b1056010.1021/acsami.8b10560 ↗
12. 10.1021/ac503215z10.1021/ac503215z ↗
13. 10.1016/j.trac.2018.10.01710.1016/j.trac.2018.10.017 ↗
14. Svirbely J. L. · Biochem. J. · 1933 · 27 · 27910.1042/bj0270960 ↗
15. 10.1016/j.ccell.2018.07.01410.1016/j.ccell.2018.07.014 ↗
16. Agus D. B. · Cancer Res. · 1999 · 59 · 4555
17. 10.1016/j.ccell.2017.02.01810.1016/j.ccell.2017.02.018 ↗
18. 10.1038/s41467-018-07257-z10.1038/s41467-018-07257-z ↗
19. 10.1021/jacs.0c0998410.1021/jacs.0c09984 ↗
20. 10.1158/0008-5472.CAN-13-047010.1158/0008-5472.CAN-13-0470 ↗
21. 10.1016/j.redox.2013.11.00510.1016/j.redox.2013.11.005 ↗
22. 10.1126/scitranslmed.300715410.1126/scitranslmed.3007154 ↗
23. 10.1111/cas.1206510.1111/cas.12065 ↗
24. 10.1016/j.freeradbiomed.2016.03.03110.1016/j.freeradbiomed.2016.03.031 ↗
25. 10.1021/acsnano.9b0703210.1021/acsnano.9b07032 ↗
26. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
27. 10.1126/sciadv.abc437310.1126/sciadv.abc4373 ↗
28. 10.1021/acssuschemeng.2c0025910.1021/acssuschemeng.2c00259 ↗
29. 10.1002/adfm.20190795410.1002/adfm.201907954 ↗
30. 10.1002/adma.20200243910.1002/adma.202002439 ↗
31. 10.1021/acsnano.7b0303710.1021/acsnano.7b03037 ↗
32. 10.1021/acsami.8b0020710.1021/acsami.8b00207 ↗
33. 10.1021/acssuschemeng.2c0096410.1021/acssuschemeng.2c00964 ↗
34. 10.1016/j.chempr.2020.02.02010.1016/j.chempr.2020.02.020 ↗
35. 10.1002/anie.20151074810.1002/anie.201510748 ↗
36. 10.1021/acsnano.0c0549910.1021/acsnano.0c05499 ↗
37. 10.1038/nature1434410.1038/nature14344 ↗
38. 10.1039/c3cs35486e10.1039/c3cs35486e ↗
39. 10.1038/nnano.2007.26010.1038/nnano.2007.260 ↗
40. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
41. 10.1002/anie.20200394910.1002/anie.202003949 ↗
42. 10.1016/j.nantod.2021.10126910.1016/j.nantod.2021.101269 ↗
43. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
44. 10.1016/j.mattod.2020.08.02010.1016/j.mattod.2020.08.020 ↗
45. 10.1021/acssuschemeng.2c0200610.1021/acssuschemeng.2c02006 ↗
46. 10.1126/science.119009410.1126/science.1190094 ↗
47. 10.1021/acs.accounts.9b0014010.1021/acs.accounts.9b00140 ↗
48. 10.1021/acssuschemeng.2c0164810.1021/acssuschemeng.2c01648 ↗
49. 10.1002/anie.20190564510.1002/anie.201905645 ↗
50. 10.1038/s41929-021-00609-x10.1038/s41929-021-00609-x ↗
51. 10.1021/jacs.1c0858110.1021/jacs.1c08581 ↗
52. 10.1002/anie.20181399410.1002/anie.201813994 ↗
53. 10.1007/s11427-019-9518-010.1007/s11427-019-9518-0 ↗
54. 10.1002/anie.20211617010.1002/anie.202116170 ↗
55. 10.1126/sciadv.aav549010.1126/sciadv.aav5490 ↗
56. 10.1039/C9CC01503E10.1039/C9CC01503E ↗
57. 10.1002/anie.20201715210.1002/anie.202017152 ↗
58. 10.1038/s41565-019-0373-610.1038/s41565-019-0373-6 ↗
59. 10.1021/jo501721210.1021/jo5017212 ↗
60. 10.1016/S0021-9258(17)41185-910.1016/S0021-9258(17)41185-9 ↗
61. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
62. 10.1002/smll.20170074010.1002/smll.201700740 ↗